Polydim-I antimicrobial activity against MDR bacteria and its model membrane interaction

Marisa Rangel1,2, Fabíola Fernandes Dos Santos Castro2, Lilian Daiene Mota-Lima1

  • 1Immunopathology Laboratory, Butantan Institute, Sao Paulo-SP, Brazil.

Plos One
|June 2, 2017
PubMed

Insights

A novel wasp-derived antimicrobial peptide, Polydim-I, shows potent activity against multi-drug resistant pathogens at low concentrations. This peptide disrupts bacterial membranes, offering a promising new strategy to combat resistant infections.

Area of Science:

  • Biochemistry
  • Microbiology
  • Pharmacology

Background:

  • Multi-drug resistant (MDR) pathogens pose a significant global public health threat.
  • Antimicrobial peptides (AMPs) offer a potential alternative to conventional antibiotics due to their broad-spectrum activity and low toxicity.
  • The need for novel antimicrobial agents effective against MDR strains is critical.

Purpose of the Study:

  • To evaluate the antimicrobial activity of Polydim-I, a recently identified wasp-derived AMP, against MDR bacteria.
  • To investigate the mechanism of action of Polydim-I, focusing on its interaction with bacterial membranes.

Main Methods:

  • Antimicrobial activity assays against standard and MDR bacterial strains.
  • Circular dichroism, Zeta potential, and FTIR spectroscopy to study peptide-membrane interactions.
  • Electrophysiology experiments to assess membrane permeabilization.

Main Results:

  • Polydim-I demonstrated potent activity against MDR strains at sub-micromolar concentrations (below 1 μg/ml), significantly lower than for standard strains.
  • The peptide exhibited a broader spectrum and higher efficiency compared to conventional drugs against MDR bacteria.
  • Polydim-I interacts with lipid bilayers, undergoes a conformational transition to a helical structure, neutralizes membrane charges, and induces pore formation.

Conclusions:

  • Polydim-I is a highly effective antimicrobial peptide against MDR pathogens, with a mechanism involving bacterial membrane disruption.
  • Its low effective concentration and potent activity highlight its potential as a therapeutic agent against resistant infections.
  • The findings support the development of wasp venom-derived peptides as a new class of antibiotics.

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
1.4K
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
14.8K
Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
3.1K
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
52